SLT As First-Line Therapy For OHT And OAG

Synopsis Glaucoma is a progressive multifactorial disease defined by significant damage to the optic nerve. This results in a progressive visual loss; if left untreated, it can lead to permanent blindness and be a significant cause of visual morbidity. Eye drops to normalize ocular pressure are one of the mainstays in glaucoma therapy. However, selective laser trabeculoplasty (SLT) has also proven to be a great alternative option for such cases. The study below is aimed at comparing both the treatment modalities for patients with glaucoma.

This “MED FACT” discusses the study- “Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): A multicentre randomized controlled trial,” from The Lancet, July 2018. Authors : Gus Gazzard et al. What was the need for this study? Primary open-angle glaucoma (OAG) and ocular hypertension…